What is the recommended colonoscopy schedule for colon cancer screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Colonoscopy Schedule for Colorectal Cancer Screening

For average-risk individuals, colonoscopy every 10 years beginning at age 50 is the recommended first-tier screening option, with annual fecal immunochemical testing (FIT) as an alternative first-tier option. 1

Screening Recommendations by Risk Category

Average-Risk Individuals:

  • Begin screening at age 50 for non-African Americans 1
  • Begin screening at age 45 for African Americans (weak recommendation) 1
  • Begin screening at age 45-49 for all average-risk individuals (newer recommendation, weak) 1
  • Recommended first-tier options:
    • Colonoscopy every 10 years 1, 2
    • Annual FIT (fecal immunochemical test) 1, 2

High-Risk Individuals:

  • Family history of colorectal cancer (CRC) or advanced adenoma in first-degree relative:

    • Begin screening at age 40 or 10 years before the age of diagnosis of the youngest affected relative, whichever is earlier 1, 3
    • Colonoscopy every 5 years 1, 3
  • Lynch Syndrome:

    • Colonoscopy every 3-5 years beginning 10 years before the age of diagnosis of the youngest affected relative 1
  • Family Colon Cancer Syndrome X:

    • Colonoscopy every 5 years beginning 10 years before the age of diagnosis of the youngest affected relative or age 40, whichever is earlier 1

Alternative Screening Options (When Colonoscopy is Declined)

For patients who decline colonoscopy and FIT, second-tier options include:

  • CT colonography every 5 years 1, 3
  • FIT-fecal DNA every 3 years 1, 2
  • Flexible sigmoidoscopy every 5-10 years 1, 2

Third-tier option:

  • Capsule colonoscopy every 5 years (if available) 1, 2

When to Stop Screening

  • Consider stopping screening at age 75 years for individuals who:

    • Are up to date with screening
    • Have had negative prior screening tests (particularly colonoscopy) 1
    • Have life expectancy less than 10 years 1
  • For individuals without prior screening:

    • Consider screening up to age 85, depending on comorbidities and life expectancy 1

Special Considerations

  • For individuals with a single first-degree relative diagnosed with CRC at ≥60 years, average-risk screening options beginning at age 40 are appropriate 2, 4

  • For those with a single first-degree relative with CRC in whom no significant neoplasia appears by age 60 years, physicians can consider expanding the interval between colonoscopies 1

  • Research suggests that individuals with multiple affected first-degree relatives may benefit from more frequent screening than the currently recommended 5-year intervals 4

  • Quality measures for colonoscopy screening should be monitored, particularly the adenoma detection rate 1, 5

Common Pitfalls and Caveats

  • Failure to recognize family history as a significant risk factor that modifies screening recommendations 1, 3

  • Not adjusting screening age for African Americans, who should begin screening at age 45 1

  • Continuing screening beyond age 75 in individuals with adequate prior screening and limited life expectancy 1

  • Not offering alternative screening methods to patients who decline colonoscopy, which may result in no screening at all 1, 2

  • Overlooking the importance of quality metrics in colonoscopy performance, which directly impacts the effectiveness of screening 1, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.